Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
1.890
-0.030 (-1.56%)
At close: May 30, 2025, 4:00 PM
1.949
+0.059 (3.14%)
After-hours: May 30, 2025, 7:35 PM EDT
Soligenix Employees
As of December 31, 2024, Soligenix had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 1 or 6.67% compared to the previous year.
Employees
16
Change (1Y)
1
Growth (1Y)
6.67%
Revenue / Employee
$146
Profits / Employee
-$599,251
Market Cap
6.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SNGX News
- 21 days ago - Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results - PRNewsWire
- 6 weeks ago - Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks - PRNewsWire
- 2 months ago - IBN Initiates Coverage of Soligenix Inc. - GlobeNewsWire
- 2 months ago - Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants - PRNewsWire
- 2 months ago - Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results - PRNewsWire
- 3 months ago - HyBryte™ Treatment Studies Presented at Two Medical Conferences in March - PRNewsWire
- 4 months ago - Soligenix to Present at BIO CEO & Investor Conference - PRNewsWire
- 4 months ago - Soligenix to Present at Upcoming Investor Conferences - PRNewsWire